The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Svenja Happe

Department of Clinical Neurophysiology

University of Göttingen

Germany

[email]@gwdg.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Clinical Neurophysiology, University of Göttingen, Germany. 2002 - 2007

References

  1. Growth hormone response to low-dose apomorphine in restless legs syndrome. Happe, S., Bachmann, C.G., Helmschmied, K., Neubert, K., Wuttke, W., Paulus, W., Trenkwalder, C. Growth Horm. IGF Res. (2007) [Pubmed]
  2. Dyskinesias due to intravenous apomorphine abuse in a patient without basal ganglia disorder. Happe, S., Sommer, M., Meller, J., Trenkwalder, C., Paulus, W. Mov. Disord. (2005) [Pubmed]
  3. Perception of sleep: subjective versus objective sleep parameters in patients with Parkinson's disease in comparison with healthy elderly controls. Sleep perception in Parkinson's disease and controls. Happe, S., Klösch, G., Lorenzo, J., Kunz, D., Penzel, T., Röschke, J., Himanen, S.L., Gruber, G., Zeitlhofer, J. J. Neurol. (2005) [Pubmed]
  4. Restless legs syndrome and sleep problems in children and adolescents with insulin-dependent diabetes mellitus type 1. Happe, S., Treptau, N., Ziegler, R., Harms, E. Neuropediatrics (2005) [Pubmed]
  5. Role of dopamine receptor agonists in the treatment of restless legs syndrome. Happe, S., Trenkwalder, C. CNS. Drugs (2004) [Pubmed]
  6. Perception of dreams and subjective sleep quality in patients with myasthenia gravis. Happe, S., Klösch, G., Zeitlhofer, J. Neuropsychobiology (2004) [Pubmed]
  7. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease. Happe, S., Tings, T., Helmschmied, K., Neubert, K., Wuttke, W., Paulus, W., Trenkwalder, C. Mov. Disord. (2004) [Pubmed]
  8. Sleep microstructure and neurodegeneration as measured by [123I]beta-CIT SPECT in treated patients with Parkinson's disease. Happe, S., Anderer, P., Pirker, W., Klösch, G., Gruber, G., Saletu, B., Zeitlhofer, J. J. Neurol. (2004) [Pubmed]
  9. Periodic leg movements in patients with Parkinson's disease are associated with reduced striatal dopamine transporter binding. Happe, S., Pirker, W., Klösch, G., Sauter, C., Zeitlhofer, J. J. Neurol. (2003) [Pubmed]
  10. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Happe, S., Sauter, C., Klösch, G., Saletu, B., Zeitlhofer, J. Neuropsychobiology (2003) [Pubmed]
  11. Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management. Happe, S. Drugs (2003) [Pubmed]
  12. The association between caregiver burden and sleep disturbances in partners of patients with Parkinson's disease. Happe, S., Berger, K. Age. Ageing (2002) [Pubmed]
  13. Scalp topography of the spontaneous K-complex and of delta-waves in human sleep. Happe, S., Anderer, P., Gruber, G., Klösch, G., Saletu, B., Zeitlhofer, J. Brain. Topogr (2002) [Pubmed]
  14. The association between disease severity and sleep-related problems in patients with Parkinson's disease. Happe, S., Lüdemann, P., Berger, K. Neuropsychobiology (2002) [Pubmed]
 
WikiGenes - Universities